Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

TransMedics Group, Inc.

TMDX Clue Score83

United States Fiscal year ends December CIK 0001756262 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

23 insiders · 441 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Waleed H Hassanein

President & CEO

$2.98M (4)

$48.40M (96) scheduled

−$45.42M

666,102

1.92%

$54.37M

+80.5%

Tamer I Khayal

Chief Commercial Officer

—

$30.34M (127) scheduled

−$30.34M

36,042

0.1039%

$2.94M

−77.0%

Abrams Capital Management, L.p. entity

10% owner

—

$28.53M (2)

−$28.53M

2,624,712

7.57%

$214.26M

—

Stephen Gordon

Chief Financial Officer

—

$16.94M (33) scheduled

−$16.94M

21,299

0.0614%

$1.74M

−78.7%

James R Tobin

Director

—

$14.29M (20)

−$14.29M

431,618

1.24%

$35.23M

−43.9%

UNITED THERAPEUTICS Corp entity

10% owner

—

$9.38M (1)

−$9.38M

2,053,240

5.92%

$167.61M

—

Edward M Basile

Director

$136.00K (1)

$6.35M (22) scheduled

−$6.21M

5,788

0.0167%

$472.47K

—

John F Carey

VP of Operations

—

$3.23M (64) scheduled

−$3.23M

14,120

0.0407%

$1.15M

+1,249%

David Weill

Director

$434.06K (3)

$3.47M (8) scheduled

−$3.03M

16,392

0.0473%

$1.34M

—

Edwin Kania

Director

$2.79M (3)

—

+$2.79M

1,186,694

3.42%

$96.87M

−38.6%

Nicholas Corcoran

See remarks

—

$2.59M (3) scheduled

−$2.59M

41,558

0.1198%

$3.39M

—

Anil P. Ranganath

See remarks

—

$1.40M (5) scheduled

−$1.40M

13,091

0.0378%

$1.07M

+6,512%

Gerardo Hernandez

Chief Financial Officer

—

$1.25M (4) scheduled

−$1.25M

31,935

0.0921%

$2.61M

—

John F Sullivan

VP of Quality & Engineering

—

$1.12M (8) scheduled

−$1.12M

14,273

0.0412%

$1.17M

−57.1%

Miriam Provost

VP, Global Regulatory Affairs

—

$1.09M (9) scheduled

−$1.09M

23,348

0.0673%

$1.91M

—

Stephanie Lovell

Director

—

$799.22K (4) scheduled

−$799.22K

5,788

0.0167%

$472.47K

—

Thomas J. Gunderson

Director

—

$722.38K (1) scheduled

−$722.38K

16,642

0.0480%

$1.36M

—

Laura Damme

VP, Clinical Affairs

—

$665.75K (3) scheduled

−$665.75K

5,685

0.0164%

$464.07K

—

Flagship Ventures Fund IV General Partner LLC entity

10% owner

—

—

—

2,650,870

7.64%

$216.39M

−43.0%

Fernando N. Araujo

See Remarks

—

—

—

22,969

0.0662%

$1.87M

—

Giovanni Cecere

Chief Commercial Officer

—

—

—

19,057

0.0550%

$1.56M

+139.0%

Matthew S. Forsyth

See Remarks

—

—

—

15,409

0.0444%

$1.26M

—

Merilee Raines

Director

—

—

—

6,981

0.0201%

$569.86K

—